Bloomberg News

Barry Callebaut, Sanofi, UBS: European Equity Preview

March 23, 2012

The following companies’ shares may have unusual moves in European (SXXP) trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index (SXXP) fell 1.2 percent to 265.49. The Stoxx 50 Index (SX5P) decreased 1.1 percent to 2,494.61. The Euro Stoxx 50 Index (SX5E), a benchmark measure for nations using the euro, declined 1.5 percent to 2,530.22.

Barry Callebaut AG (BARN) : The world’s largest maker of bulk chocolates will invest $43.4 million over the next 10 years in west and central Africa and in Indonesia to improve the quality of cocoa beans, Fraternité Matin reported, without saying where it got the information. The shares decreased 1.4 percent to 882.5 Swiss francs.

Castellum AB (CAST) : The Swedish real estate company elected Charlotte Stroemberg as chairman of the board following Jan Kvarnstroem’s decision to resign from the post. The shares fell 1.2 percent to 87.75 kronor.

Sanofi (SAN) : France’s biggest drugmaker lost an appeals court ruling on its patent-infringement claims against Roche Holding AG (ROG)’s Genentech and Biogen Idec Inc. (BIIB US) for the cancer drugs Rituxan and Avastin. Sanofi dropped 1 percent to 58.16 euros. Roche fell 0.9 percent to 158.60 Swiss francs.

UBS AG (UBSN) : The Swiss bank hired Andrea Orcel, a top Bank of America Corp. dealmaker, as co-head of its investment bank to help revive a division rocked by key departures and last year’s $2.3 billion loss from unauthorized trading. The shares declined 0.5 percent to 12.92 Swiss francs.

To contact the reporter on this story: Joseph Ciolli in New York at

To contact the editor responsible for this story: Nick Baker at

The Good Business Issue
blog comments powered by Disqus